Author: Mohammadzadeh, Sara; Khabiri, Alireza; Roohvand, Farzin; Memarnejadian, Arash; Salmanian, Ali Hatef; Ajdary, Soheila; Ehsani, Parastoo
Title: Enhanced-Transient Expression of Hepatitis C Virus Core Protein in Nicotiana tabacum, a Protein With Potential Clinical Applications Document date: 2014_11_24
ID: 3posyr5n_39
Snippet: Taken together, the present study was the first (to our best of knowledge) to address construction of a transient tobacco expression system for HCVcp. For highest possible expression efficiency, the HCVcp DNA sequence was codon optimized (based on the CAI for nuclear-encoded genes of tobacco), destabilizing of the GGTAAG sequence in the native HCVcp coding sequence was altered and Kozak and KDEL sequences were included at the 5' and 3' ends, resp.....
Document: Taken together, the present study was the first (to our best of knowledge) to address construction of a transient tobacco expression system for HCVcp. For highest possible expression efficiency, the HCVcp DNA sequence was codon optimized (based on the CAI for nuclear-encoded genes of tobacco), destabilizing of the GGTAAG sequence in the native HCVcp coding sequence was altered and Kozak and KDEL sequences were included at the 5' and 3' ends, respectively. Two types of plant expression vectors (PVX-based and classic pBI121 binary) for HCVcp were constructed and their levels of protein expression in the presence and absence of P19 co-agroinfiltration were compared. The results indicated the significant effect of our approach in enhancement of the expression levels for pHCVcp. To our knowledge, all the above mentioned reports were first of their kinds for HCVcp and provided valuable information for plant-based expression studies on this antigen. The preliminary results (with five HCV positive sera) showed that plant-HCVcp has the capability to capture anti-HCVcp antibodies for potential clinical applications which should be further evaluated and confirmed by statistically acceptable numbers of positive sample sera. The next steps might be standardization of pHCVcp for application in diagnostic ELISA through application of positive sera with determined viral loads as well as precisely predetermined standard positive sera together with high number of optimization studies with different concentrations of antigen/antibody in ELISA with precise statistical analyses and evaluation of the pHCVcp for immunization studies.
Search related documents:
Co phrase search for related documents- absence presence and clinical application: 1, 2, 3, 4
- absence presence and co agroinfiltration: 1, 2
- absence presence and determined viral load: 1
- absence presence and dna sequence: 1, 2, 3, 4, 5, 6
- absence presence and expression level: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antigen antibody and clinical application: 1, 2
- antigen antibody and co agroinfiltration: 1
- antigen antibody and determined viral load: 1, 2
- antigen antibody and diagnostic ELISA application: 1
- antigen antibody and dna sequence: 1
- antigen antibody and expression efficiency: 1
- antigen antibody and expression level: 1, 2, 3, 4, 5
- clinical application and different concentration: 1
- clinical application and dna sequence: 1, 2, 3
- clinical application and expression level: 1, 2, 3, 4, 5, 6, 7
- co agroinfiltration and expression level: 1, 2, 3
- code sequence and determined viral load: 1
- code sequence and expression level: 1
- codon optimize and expression efficiency: 1
Co phrase search for related documents, hyperlinks ordered by date